title: [Guidelines for the management of patients with atrial fibrillation. Executive summary].
authors.forename: Valentín
authors.initials: V
authors.lastname: Fuster
authors.forename: Lars E
authors.initials: LE
authors.lastname: Rydén
authors.forename: David S
authors.initials: DS
authors.lastname: Cannom
authors.forename: Harry J
authors.initials: HJ
authors.lastname: Crijns
authors.forename: Anne B
authors.initials: AB
authors.lastname: Curtis
authors.forename: Kenneth A
authors.initials: KA
authors.lastname: Ellenbogen
authors.forename: Jonathan L
authors.initials: JL
authors.lastname: Halperin
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Le Heuzey
authors.forename: G
authors.initials: G
authors.lastname: Neal Kay
authors.forename: James E
authors.initials: JE
authors.lastname: Lowe
authors.forename: S
authors.initials: S
authors.lastname: Bertil Olsson
authors.forename: Eric N
authors.initials: EN
authors.lastname: Prystowsky
authors.forename: Juan L
authors.initials: JL
authors.lastname: Tamargo
authors.forename: Samuel
authors.initials: S
authors.lastname: Wann
mesh_terms: D000465:Algorithms; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000145:classification / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D017115:Catheter Ablation / Q000379:methods; D004554:Electric Countershock / Q000379:methods*; D006801:Humans; D011788:Quality of Life; D013923:Thromboembolism / Q000517:prevention & control
chemical_list: D000889:Anti-Arrhythmia Agents